A Phase I study of induction chemotherapy with S-1 and Cisplatin plus intraperitoneal administration of Docetaxel for gastric cancer with peritoneal disseminatio
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000002524
- Lead Sponsor
- Department of Surgery Graduate School of Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Not provided
1)Active bleeding from the tumor 2)Paralysis of intestine or ileus 3)Diarrhea(watery stool) 4)Synchronous multicancer 5)Pleural effusion or ascites requiring control 6)Serious comorbidity including -Serious infection -Uncontrollable diabetes mellitus -Heart failure requireing control -Uncontrolled arrhythmia or angina -Severe phyciatric disease -Interstitial pneumonitis or fibroid lung 7)Myocardial infarction within 6 months 8)Patient who has experienced serious allergy for any drug or polysorbate 80 in the past 9)Patient who is pregnant or in lactation, or wish to become pregnant during this study.Male patient who intends to make someone pregnant during this study 10)Patient who requires continuous use of flucytosine 11)Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method